Lujo virus: current concepts

References

• Enria DA, Mills JN, Bausch D, Shieh W, Peters CJ. Arenavirus Infections. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical Infectious Diseases:Pprinciples, Pathogens, and Practice. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2011:449–461.
   Google Scholar
• Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg. 1970;19(4):680–691.
   PubMed Web of Science ®Google Scholar
• Sewlall NH, Richards G, Duse A, et al. Clinical features and patient management of lujo hemorrhagic fever. PLoS Negl Trop Dis. 2014;8(11):e3233.
   Web of Science ®Google Scholar
• Paweska JT, Sewlall NH, Ksiazek TG, et al; Outbreak Control and Investigation Teams. Nosocomial outbreak of novel arenavirus infection, Southern Africa. Emerg Infect Dis. 2009;15(10):1598–1602.
   PubMed Web of Science ®Google Scholar
• Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation. 2004;109(21):2560–2565.
   Web of Science ®Google Scholar
• Hackman DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population based cohort analysis. Lancet. 2006;367(9508):413–418.
   Web of Science ®Google Scholar
• Clergy JC, Wilson SM, Oram JD. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. Virus Res. 1991;18(2–3):151–164.
   Web of Science ®Google Scholar
• Demby AH, Chamberlain J, Brown DW, Clegg CS. Early diagnosis of lassa fever by reverse transcriptase-PCR. J Clin Microbiol. 1994;32(12):2898–2903.
   Web of Science ®Google Scholar
• Briese T, Paweska JT, McMullan LK, et al. Genetic detection and characterization of lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa. PLoS Pathog. 2009;5(5):e1000455.
   PubMed Web of Science ®Google Scholar
• Buchmeier MJ, de la Torre JC, Peters CJ. Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007:1791–1827.
   Google Scholar
• Fischer-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of nosocomial lassa fever in Nigeria: the high price of poor medical practice. BMJ. 1995;311(7009):857–859.
   Google Scholar
• Palacios G, Druce J, Du L, et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Eng J Med. 2008;358(10):991–998.
   PubMed Web of Science ®Google Scholar
• Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. 1. Clinical description and pathological findings. Am J Trop Med Hyg. 1970;19(4):670–676.
   PubMed Web of Science ®Google Scholar
• Charred RN, de Lamballerie X, Emonet S. Phylogeny of the genus Arenavirus. Curr Opin Microbiol. 2008;11(4):362–368.
   Web of Science ®Google Scholar
• Ishii A, Thomas Y, Moonga L, et al. Novel Arenavirus, Zambia. Emerg Infect Dis. 2011;17(10):1921–1924.
   Web of Science ®Google Scholar
• Ishii A, Thomas Y, Moonga L, et al. Molecular surveillance and phylogenetic analysis of Old World arenaviruses in Zambia. J Gen Virol. 2012;93(Pt 10):2247–2251.
   Google Scholar
• Troup JM, White HA, Fom AL, Carey DE. An outbreak of Lassa fever on Jos Plateau, Nigeria, in January – February 1970. A preliminary report. Am J Trop Med Hyg. 1970;19(4):695–696.
   Web of Science ®Google Scholar
• Urata S, Yasuda J. Molecular mechanisms of arenavirus assembly and budding. Viruses. 2012;4(10):2049–2079.
   PubMed Web of Science ®Google Scholar
• Cao W, Henry MD, Borrow P, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus. Science. 1998;282(5396):2079–2081.
   PubMed Web of Science ®Google Scholar
• Radoshitzky SR, Abraham J, Spiropoulou CF, et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature. 2007;446(7131):92–96.
   PubMed Web of Science ®Google Scholar
• Tani H, Iha K, Shimojima M, et al. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol. 2014;88(13):7317–7330.
   PubMed Web of Science ®Google Scholar
• Urata S, Weber J, Storm N, et al. Analysis of assembly ad budding of lujo virus. J Virol. 2015;90(6):3257–3261.
   Web of Science ®Google Scholar
• Bausch DG. Viral hemorrhagic fevers. In: Goldman’s Cecil Medicine. Goldman L, Schafer A, editors. 24th ed. Philadelphia, PA: Elsevier Saunders; 2011:2704
   Google Scholar
• Bausch DG, Sprecher AG, Jeffs B, Boumandouki P. Treatment of marburg and ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res. 2008;78(1):150–161.
   Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314(1):20–26.
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Ksiazek TG, Rollin PE, et al. Treatment of bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis. 1997;24(4):718–722.
   PubMed Web of Science ®Google Scholar
• Barry M, Russi M, Armstrong L, et al. Brief report: treatment of a laboratory-acquired Sabia virus infection. N Engl J Med. 1995;333(5):294–296.
   PubMed Web of Science ®Google Scholar
• Enria DA, Briggiler AM, Sanchez Z. Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008;78(1):132–139.
   PubMed Web of Science ®Google Scholar
• Parker WB. Metabolism and antiviral activity of ribavirin. Virus Res. 2005;107(2):165–171.
   PubMed Web of Science ®Google Scholar
• Moreno H, Gallego I, Sevilla N, de la Torre JC, Domingo E, Martín V. Ribavirin can be mutagenic for arenaviruses. J Virol. 2011;85(14):7246–7255.
   PubMed Web of Science ®Google Scholar
• Kalra S, Kelkar D, Galwankar SC, et al. The emergence of ebola as a global health security threat: from “lessons learned” to coordinated multilateral containment efforts. J Glob Infect Dis. 2014;6(4):164–177.
   PubMedGoogle Scholar
• Bird BH, Dodd KA, Erickson BR, et al. Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus. PLoS Negl Trop Dis. 2012;6(8):e1801.
   Web of Science ®Google Scholar
• Paweska JT, Jansen van Vuuren P, Weyer J. Lujo Virus Hemorrhagic Fever. In: Viral Hemorrhagic Fevers. Singh SK, Ruzek D, editors. 1st ed. CRC Press London; 2013:287–305.
   Google Scholar
• Paweska JT. Lujo virus hemorrhagic fever. In: Clinical Case Study of Emerging Infectious Diseases. O Ergonul, F Can, M Akova, L Madoff, editors. Elsevier/Academic Press London; 2014:95–110.
   Google Scholar
• Anderson KG, Shapiro BJ, Matranga CB, et al. Clinical sequencing uncovers origins and evolution of lassa virus. Cell. 2015;162(4):738–750.
   Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155(3):445–455.
   PubMed Web of Science ®Google Scholar
• McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. 1987;155(3):437–444.
   PubMed Web of Science ®Google Scholar
• Ogbu O, Ajuluchukwa E, Uneke CJ. Lassa fever in West-African sub-region: an overview. J Vector Borne Dis. 2007;44(1):1–11.
   PubMedGoogle Scholar